Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives.

ABSTRACT: In April 2024, a hybrid meeting organized by the WHO, PAHO, and MPP during the World Bank Spring Meetings focused on financing mRNA-based technologies in Low- and Middle-Income Countries (LMICs). This meeting sought to engage multilateral development banks (MDBs) and stakeholders in financing the expansion of vaccine production and enhancing pandemic preparedness. The COVID-19 pandemic underscored the disparities in vaccine production and distribution, highlighting the need for localized production to improve global health equity. The WHO's mRNA Technology Transfer Programme, initiated in 2021, aims to build local capacity for mRNA vaccine development and manufacturing. Key sessions covered during the meeting include innovative investment models, with MDBs discussing funding instruments an

SUBMITTER: Abreu AJL 

PROVIDER: S-EPMC11861337 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature